Oncology in Clinical Practice

Oncology in Clinical Practice Dane kontaktowe, mapa i wskazówki, formularz kontaktowy, godziny otwarcia, usługi, oceny, zdjęcia, filmy i ogłoszenia od Oncology in Clinical Practice, Zdrowie i medycyna, Ulica Roentgena 5, Warsaw.

The 2025 ESMO Congress in Berlin showcased important uro-oncology trials that may reshape treatment for bladder, prostat...
23/04/2026

The 2025 ESMO Congress in Berlin showcased important uro-oncology trials that may reshape treatment for bladder, prostate, and kidney cancers. Key findings from the Presidential Session highlighting the latest advances and potential new standards of care are summarized in this review paper.

Authors: Dawid Sigorski, Błażej Urbanowicz, Małgorzata Osmola, Michał Wilk

Mucinous cancers with peritoneal involvement can challenge routine diagnostic pathways. This case report shows that imag...
08/04/2026

Mucinous cancers with peritoneal involvement can challenge routine diagnostic pathways. This case report shows that imaging, pathology, and laboratory tests may still fail to identify the primary site, directly affecting treatment decisions. It also highlights the need for further advances in genetic profiling, multidisciplinary care, and assessment for cytoreductive surgery with HIPEC.

Authors: Martyna Świerkowska, Tomasz Sarosiek

A new bibliometric and altmetric study highlights the top 100 most cited articles on CDK4/6 inhibitors in cancer researc...
07/04/2026

A new bibliometric and altmetric study highlights the top 100 most cited articles on CDK4/6 inhibitors in cancer research and shows that academic impact strongly correlates with digital visibility. The findings suggest that social media and online attention may reflect scientific influence in this field.

Authors: Bilgeşah Kiliçtaş, Ahmet Ufuk Kiliçtaş, Murat Araz

In a recent scoping review, stereotactic body radiotherapy (SBRT) shows promise for patients with inoperable lung cancer...
02/04/2026

In a recent scoping review, stereotactic body radiotherapy (SBRT) shows promise for patients with inoperable lung cancer, including non-small cell lung cancer and other subtypes, offering favorable survival outcomes with minimal toxicity.

Authors: Chara Chantzara, Eleni Tzanetou, Hatham El-Ghobashy, Sotiris Christoforou, Datis Kalali

This prospective cohort study assessed acute and late toxicity of moderate hypo-fractionated IMRT with simultaneous inte...
01/04/2026

This prospective cohort study assessed acute and late toxicity of moderate hypo-fractionated IMRT with simultaneous integrated boost in prostate cancer patients. After 30 months of follow-up, tumor control was excellent and chronic GU and GI toxicity rates were low, with most adverse effects being mild and well tolerated.

Authors: Hanan Fawzy Mohamed Abdallah, Hala Mohamed Ahmed Elshenshawy, Rasha Abd El-Ghany Mohamed Khedr, Maiy Abdul-Raheim Mohammad Alshahat, Amal Ahmed Fouad Halim

Diffuse gliomas with IDH mutations represent a major subgroup of brain tumors in adults. This review presents the molecu...
25/03/2026

Diffuse gliomas with IDH mutations represent a major subgroup of brain tumors in adults. This review presents the molecular basis of these tumors and clinical evidence on vorasidenib, the first IDH1/2 inhibitor. Results from the INDIGO study showed prolonged progression-free survival, slower tumor growth, and delayed need for further treatment, while real-world data confirmed the activity and tolerability of vorasidenib in a broader patient population.

Authors: Tomasz Kubiatowski, Ewa Iżycka-Świeszewska

How much do breast cancer patients in Poland pay beyond public insurance coverage? This study shows that 90.6% of respon...
24/03/2026

How much do breast cancer patients in Poland pay beyond public insurance coverage? This study shows that 90.6% of respondents reported additional expenses for travel, private consultations/diagnostics, medications, dietary supplements, and rehabilitation, which they personally financed.

Authors: Mikołaj Bartoszkiewicz, Joanna Kufel-Grabowska, Zsuzsanna Beretzky, Péter Balázs, Paweł Burchardt, Valentin Brodszky

This case report presents desmoplastic/nodular medulloblastoma with cervico-dorsal spinal dissemination in a 2-year-old ...
18/03/2026

This case report presents desmoplastic/nodular medulloblastoma with cervico-dorsal spinal dissemination in a 2-year-old patient. The authors describe rare co-expression of nuclear OLIG2 and nucleolar H3K27me3, offering insights into an alternative (speculative) biological interpretation.

Authors: Gabriele Gaggero, Barbara Cafferata, Chiara Trambaiolo Antonelli, Jacopo Ferro, Valerio Gaetano Vellone

This case report illustrates the role of intraoperative cytology in identifying high-grade ependymoma and supporting imm...
16/03/2026

This case report illustrates the role of intraoperative cytology in identifying high-grade ependymoma and supporting immediate surgical decision-making, while emphasizing the value of subsequent molecular analyses in refining diagnosis, prognosis, and treatment planning in paediatric CNS tumours.

Authors: Gabriele Gaggero, Barbara Cafferata, Gianluca Piatelli, Manuela Ferraro, Valerio Gaetano Vellone

How does cancer prevalence in Poland compare with other EU countries? This study analyses national and international dat...
12/03/2026

How does cancer prevalence in Poland compare with other EU countries? This study analyses national and international data to assess cancer prevalence in Poland in the European context and highlights why prevalence should be used more widely when planning oncological care—because lower prevalence does not automatically mean a lower cancer burden for healthcare systems.

Authors: Joanna A. Didkowska, Urszula Wojciechowska

This cross-national review of oncological data analysed epidemiology, survival, healthcare spending, screening, and acce...
10/03/2026

This cross-national review of oncological data analysed epidemiology, survival, healthcare spending, screening, and access to oncology medicines across 10 European countries (Poland, Czechia, Estonia, Germany, Spain, Slovenia, the Netherlands, the United Kingdom, Italy, and Finland) using information from international sources. The authors highlight the need for multidimensional reform strategies to improve the efficiency and equity of oncology systems in Europe.

Authors: Krzysztof Nojszewski, Robert Plisko, Kaja Kostrzewska, Klaudia Janiszewska, Magdalena Władysiuk

This comprehensive review evaluates the safety and efficacy of atezolizumab in patients with coexisting NSCLC and COPD. ...
09/03/2026

This comprehensive review evaluates the safety and efficacy of atezolizumab in patients with coexisting NSCLC and COPD. Analysis of both real-world data and randomized trials allowed the authors to conclude that atezolizumab demonstrates significant efficacy and a favorable safety profile in NSCLC patients with COPD.

Authors: Akram Hasan Kareem, Samer Imad Mohammed, Ahmed Abdali Shihad

Adres

Ulica Roentgena 5
Warsaw
02-781

Strona Internetowa

https://www.researchgate.net/journal/Oncology-in-Clinical-P

Ostrzeżenia

Bądź na bieżąco i daj nam wysłać e-mail, gdy Oncology in Clinical Practice umieści wiadomości i promocje. Twój adres e-mail nie zostanie wykorzystany do żadnego innego celu i możesz zrezygnować z subskrypcji w dowolnym momencie.

Skontaktuj Się Z Praktyka

Wyślij wiadomość do Oncology in Clinical Practice:

Udostępnij